Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01901978 · ClinicalTrials.gov registry record · NA

Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents

A NA study of Obesity and Insulin Resistance, sponsored by Yale University.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT01901978: Completed NA study of Obesity and Insulin Resistance, sponsored by Yale University.

NCT01901978 is a NA study of Obesity and Insulin Resistance that has completed, run by Yale University. The registered enrollment target is 14 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01901978, a NA study of Obesity and Insulin Resistance, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the changes in subcutaneous adipocyte size, number and gene expression after weight loss and to assess whether those changes contribute to decreases in ectopic fat accumulation and insulin resistance in women between ages of 16-32.

Primary Outcome

To assess in young women, the effects of weight loss on abdominal fat distribution.

Interventions

  • BEHAVIORAL Caloric restrictive diet

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2011-05
Est. Completion 2018-08
Phase NA
Yale University

1,492 total trials

What the finished NCT01901978 record still lists

NCT01901978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Caloric restrictive diet is the first listed.

NCT01901978 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT01901978 about?

NCT01901978 is a clinical study titled "Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents". The purpose of this study is to investigate the changes in subcutaneous adipocyte size, number and gene expression after weight loss and to assess whether those changes contribute to decreases in ectopic fat accumulation and insulin resistance in women between ages of 16-32.

What is the current status of trial NCT01901978?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2011-05. Estimated completion is 2018-08.

What conditions does trial NCT01901978 study?

This clinical trial studies the following conditions: Obesity, Insulin Resistance.

What interventions are being tested in trial NCT01901978?

The interventions under investigation include: Caloric restrictive diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT01901978?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01901978 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01901978's enrollment target sits among peer trials

14 1009th of 1053 higher than 44 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01901978, the US trial registry maintained by the National Library of Medicine. NCT01901978 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.